PTSM: Pharmaceutical Technology Sourcing and Management-03-06-2009

Weakening fundamentals in 2008 and projected for 2009 dampen the outlook for pharmaceutical chemical outsourcing, but near-term growth and investments levels in R&D and capital spending remain fairly robust.

Dire circumstances are driving major drug companies to seek out CRO partners. This article contains bonus online-exclusive material.

Gilles Cottier, SAFC's new president, plans to continue a growth strategy that emphasizes value-added technologies positions, growth in Asia, and customization in its supply-chain solutions.